Concepedia

Catharina Müller‐Thomas

CM

Statistics

Publications

12

Citations

516

H-Index

12

Active since

2006

Affiliations

Technical University of Munich(Current)

TUM Klinikum

Heidelberg University

Praxis für Hämatologie und Onkologie

German Cancer Research Center

Catharina Müller‐Thomas is an author at Technical University of Munich specializing in hematology, medicine, and myelodysplastic syndromes.

ORCID

Publications per year

2006–2019

12

Publications

12

Blockade of BCL-2 proteins efficiently induces apoptosis in progenitor cells of high-risk myelodysplastic syndromes patients

Stefanie Jilg, Veronika Reidel, Catharina Müller‐Thomas et al. · Leukemia · 2015 · 106 citations

, , +17

Outcome of Lower-Risk Patients With Myelodysplastic Syndromes Without 5q Deletion After Failure of Erythropoiesis-Stimulating Agents

Sophie Park, Jean-François Hamel, Andréa Toma et al. · Journal of Clinical Oncology · 2017 · 99 citations · Full text

, , +14

Targeted positron emission tomography imaging of CXCR4 expression in patients with acute myeloid leukemia

Peter Herhaus, Stefan Habringer, Kathrin Philipp‐Abbrederis et al. · Haematologica · 2016 · 66 citations · Full text

, , +17

Direct modulation of the bone marrow mesenchymal stromal cell compartment by azacitidine enhances healthy hematopoiesis

Catharina Wenk, Anne-Kathrin Garz, Sonja Grath et al. · Blood Advances · 2018 · 41 citations · Full text

, , +13

Venetoclax with azacitidine targets refractory MDS but spares healthy hematopoiesis at tailored dose

Stefanie Jilg, Richard Hauch, Johanna Kauschinger et al. · Experimental Hematology and Oncology · 2019 · 40 citations · Full text

, , +16

1–5 of 12